That's a great question.
I will frame that question around the federal R and D review that was done, which pointed out Canada's relative position on direct versus indirect mechanisms, such as SR and ED, which is an indirect tax measure. Organizations that focus on direct funding—SDTC is one—are disproportionately smaller than our competitors. The recommendation to re-shift that balance is a good one, especially given that all the countries we compete with have more direct funding mechanisms as a proportion than indirect. In terms of impact to the folks we deal with, most of them are small and medium-sized enterprises. In fact, 86% of the folks we invest in are small and medium-sized enterprises. They're the ones that have the most difficult time accessing funds like SR and ED. For them, seeing the shift into direct funding mechanisms is very welcome.